Combination of the Hypercvad Regimen with Dasatinib Is Effective in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LB).

被引:25
|
作者
Ravandi, Farhad
Kantarjian, Hagop M.
Cortes, Jorge
Thomas, Deborah A.
Faderl, Stefan
Jones, Dan
Jabbour, Elias [1 ]
Koller, Charles
Dara, Samuel [1 ]
Garris, Rebecca
Kebriaei, Partow
Borthakur, Gautam
Ferrajoli, Alessandra
O'Brien, Susan
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
关键词
D O I
10.1182/blood.V114.22.636.636
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:806 / 807
页数:2
相关论文
共 50 条
  • [31] LYMPHOID BLAST CRISIS IN CHRONIC MYELOID-LEUKEMIA AND PHILADELPHIA POSITIVE ACUTE LYMPHOID LEUKEMIA
    JANOSSY, G
    ROBERTS, M
    GREAVES, MF
    WOODRUFF, R
    PIPPARD, M
    PRENTICE, G
    HOFFBRAND, AV
    BOLLETTINO DELL ISTITUTO SIEROTERAPICO MILANESE, 1978, 57 (03): : 355 - 359
  • [32] Dasatinib (BMS-354825) in patients with chronic myeloid leukemia (CML) and Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph plus ALL) who are resistant or intolerant to imatinib: Update of a phase I study.
    Sawyers, CL
    Kantarjian, H
    Shah, N
    Cortes, J
    Paquette, R
    Donato, N
    Nicoll, J
    Bleickardt, E
    Chen, TT
    Talpaz, M
    BLOOD, 2005, 106 (11) : 16A - 16A
  • [33] Philadelphia chromosome positive acute myeloid leukemia or de novo chronic myeloid leukemia-blast phase?
    Frankfurt, Olga
    Platanias, Leonidas C.
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 1 - 2
  • [34] Combination of hyper-CVAD with imatinib mesylate (STI571) for Philadelphia (Ph)-positive adult acute lymphoblastic leukemia (ALL) or chronic myelogenous leukemia in lymphoid blast phase (CML-LBP).
    Thomas, DA
    Cortes, J
    Giles, FJ
    Faderl, S
    O'Brien, S
    Rios, MB
    Issa, JP
    García-Manero, G
    Koller, C
    Capdeville, R
    Talpaz, M
    Kantarjian, H
    BLOOD, 2001, 98 (11) : 803A - 803A
  • [35] The role of dasatinib in patients with Philadelphia (Ph) positive acute lymphocytic leukemia (ALL) and chronic myeloid leukemia (CML) relapsing after stem cell transplantation (SCT).
    Atallah, Ehab
    Kantarjian, Hagop
    De Lima, Marcos
    Borthakur, Gautam
    Wierda, William
    Champlin, Richard
    Cortes, Jorge
    BLOOD, 2006, 108 (11) : 209B - 209B
  • [36] Hypercvad Plus Imatinib or Dasatinib for Patients with Lymphoid Blastic Phase of Chronic Myeloid Leukemia
    Strati, Paolo
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    O'Brien, Susan M.
    Jabbour, Elias J.
    Quintas-Cardama, Alfonso
    Borthakur, Gautam
    Faderl, Stefan
    Ravandi, Farhad
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
  • [37] Olverembatinib (HQP1351) Combined with Chemotherapy Is an Effective and Safe Treatment in Patients with Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL) and Chronic Myeloid Leukemia in Lymphoid Blast Phase (CML-LBP) That Failed TKI-Based Regimens
    Li, Zongru
    Ting, Zhao
    Hu, Lijuan
    Duan, Wenbing
    Jiang, Qian
    BLOOD, 2023, 142
  • [38] Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia
    Pavlovsky, Carolina
    Chan, Onyee
    Talati, Chetasi
    Pinilla-Ibarz, Javier
    FUTURE ONCOLOGY, 2019, 15 (03) : 257 - 269
  • [39] Subgroup analysis from a phase II trial of ponatinib and blinatumomab in relapsed/refractory (R/R) Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in lymphoid blast phase
    Zoghbi, Marianne
    Jabbour, Elias
    Haddad, Fadi
    Short, Nicholas James
    Nasnas, Cedric Christophe
    Macaron, Walid
    Nasr, Lewis Fady
    Jain, Nitin
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Daver, Naval Guastad
    Chien, Kelly Sharon
    Valero, Yesid Alvarado
    Issa, Ghayas C.
    Mayor, Ejiroghene
    Deen, Wuliamatu
    Thankachan, Jennifer
    Garris, Rebecca
    Ravandi, Farhad
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [40] DasatinibIn Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Susan J. Keam
    BioDrugs, 2008, 22 : 59 - 69